Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sheinfeld

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Acta Cytologica|July 1, 1994
Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigensP M Sagerman, P E Saigo, J Sheinfeld, et al.
BJU International|March 27, 2003
The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumoursM S McGuire, F Rabbani, H Mohseni, et al.
Seminars in Urology|August 1, 1993
Biological markers of prognosis in transitional cell carcinoma of the bladder: current conceptsA G Aprikian, A S Sarkis, V E Reuter, et al.
Seminars in Surgical Oncology|September 1, 1992
Cell surface differentiation antigens of normal urothelium and bladder tumorsG Dalbagni, V E Reuter, J Sheinfeld, et al.
The Journal of Urology|August 1, 1994
Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrenceM D Schwalb, H W Herr, P C Sogani, et al.
The Journal of Urology|January 1, 1996
Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gammaG Gastl, T Ebert, C L Finstad, et al.
British Journal of Urology|November 1, 1994
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancerA G Aprikian, W R Fair, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancerR J Motzer, J Sheinfeld, M Mazumdar, et al.
International Journal of Oncology|May 17, 2011
P53 nuclear overexpression and disease progression in ta-bladder carcinomaA Sarkis, Z Zhang, C Cordoncardo, et al.
Cancer|June 15, 1994
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experienceJ Vieweg, W F Whitmore, H W Herr, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Acta Cytologica|July 1, 1994
Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigensP M Sagerman, P E Saigo, J Sheinfeld, et al.
BJU International|March 27, 2003
The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumoursM S McGuire, F Rabbani, H Mohseni, et al.
Seminars in Urology|August 1, 1993
Biological markers of prognosis in transitional cell carcinoma of the bladder: current conceptsA G Aprikian, A S Sarkis, V E Reuter, et al.
Seminars in Surgical Oncology|September 1, 1992
Cell surface differentiation antigens of normal urothelium and bladder tumorsG Dalbagni, V E Reuter, J Sheinfeld, et al.
The Journal of Urology|August 1, 1994
Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrenceM D Schwalb, H W Herr, P C Sogani, et al.
The Journal of Urology|January 1, 1996
Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gammaG Gastl, T Ebert, C L Finstad, et al.
British Journal of Urology|November 1, 1994
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancerA G Aprikian, W R Fair, V E Reuter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2000
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancerR J Motzer, J Sheinfeld, M Mazumdar, et al.
International Journal of Oncology|May 17, 2011
P53 nuclear overexpression and disease progression in ta-bladder carcinomaA Sarkis, Z Zhang, C Cordoncardo, et al.
Cancer|June 15, 1994
The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The Memorial Sloan-Kettering Cancer Center experienceJ Vieweg, W F Whitmore, H W Herr, et al.
Pageof 7